.Pharmacolibrary.Drugs.ATC.N.N03AG01_1 .Pharmacolibrary.Drugs.ATC.N.N03AG01_1| name: | ValproicAcid_1 |
| ATC code: | N03AG01_1 | route: | intravenous |
| n-compartments | 2 |
Valproic acid is an antiepileptic drug (AED) used primarily for the treatment of epilepsy, bipolar disorder, and prevention of migraine headaches. It is a broad-spectrum anticonvulsant approved for use in many countries, including the US and EU.
Pharmacokinetic parameters in healthy adults after intravenous administration (bolus injection).
Sitaruno, S, et al., & Setthawatcharawanich, S (2024). Population Pharmacokinetics and Loading Dose Optimization of Intravenous Valproic Acid in Hospitalized Thai Patients. Journal of clinical pharmacology 64(11) 1343–1350. DOI:10.1002/jcph.6102 PUBMED:https://pubmed.ncbi.nlm.nih.gov/39073986
Park, HM, et al., & Yim, DS (2002). Population pharmacokinetics of intravenous valproic acid in Korean patients. Journal of clinical pharmacy and therapeutics 27(6) 419–425. DOI:10.1046/j.1365-2710.2002.00440.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/12472981
Bateman, RM, et al., & Prandi, E (2016). 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. Critical care (London, England) 20(Suppl 2) 94–None. DOI:10.1186/s13054-016-1208-6 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27885969